0.00(0%)

Last update at

Day Range

LowHigh

52 Week Range

LowHigh

Fundamentals

Previous Close -
Market Cap-
Volume
P/E Ratio-
Dividend Yield-%
Revenue TTM-
Revenue Per Share TTM-
Gross Profit TTM -
Diluted EPS TTM-

Overview
Financials
Peer Comparison
Reports
Stock Research & News

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting
Fri 16 May 25, 12:30 PM
FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update
Wed 14 May 25, 08:30 PM
FibroBiologics Presents at the ThymUS 2025 Meeting
Tue 29 Apr 25, 01:15 PM
FibroBiologics Presenting at the ThymUS 2025 Meeting
Tue 29 Apr 25, 01:15 PM
FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean
Fri 11 Apr 25, 12:30 PM
FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair
Wed 02 Apr 25, 12:30 PM
FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update
Mon 31 Mar 25, 08:25 PM
FibroBiologics Announces 2025 Annual Meeting of Stockholders
Thu 27 Mar 25, 12:30 PM
FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting
Fri 21 Mar 25, 12:30 PM
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
Fri 14 Mar 25, 12:35 PM

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown

Breakdown

Breakdown

Peer Comparison

Sector: Industry:

Company	Change ()	Price ()	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)

Reports Covered

View All

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.